Pfizer Inc. (PFE) vs Target Corporation (TGT)
A side-by-side comparison of Pfizer Inc. and Target Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.
Different business models: PFE is classified in Healthcare; TGT is classified in Consumer Defensive. Margin, capital intensity, and valuation differences should be interpreted in that sector context.
PFE
Pfizer Inc.
$25.25HealthcareDelayed quote: Jul 28, 2026, 4:02 PM EDT
TGT
Target Corporation
$144.18Consumer DefensiveDelayed quote: Jul 28, 2026, 4:00 PM EDT
Total return — PFE vs TGT
growth of $100 · dividends reinvested · last 30yPFE +543.3%TGT +3345.1%TGT compounded faster
Log scale — wide-divergence pair
PFE TGT
PFE vs TGT: by the numbers
- •PFE is the larger company ($143.91B vs $65.49B market cap).
- •TGT trades at the lower trailing earnings multiple (18.54 vs 18.83 P/E), one valuation lens rather than an overall verdict.
- •PFE converts more revenue to profit (11.83% vs 3.24% net margin).
- •PFE grew revenue faster over the past five years (8.22% vs -0.29% CAGR).
- •PFE pays the higher dividend yield (6.97% vs 3.25%).
Metrics side by side
Valuation
| Metric | PFE | TGT |
|---|---|---|
| P/E ratio | 18.83 | 18.54 |
| Forward P/E | 8.38 | 19.22 |
| P/S ratio | 2.23 | 0.60 |
| P/B ratio | 1.57 | 3.90 |
| EV / EBITDA | 9.72 | 9.98 |
| FCF yield | 6.71% | 4.89% |
Profitability
| Metric | PFE | TGT |
|---|---|---|
| Gross margin | 69.35% | 28.14% |
| Operating margin | 23.45% | 4.49% |
| Net margin | 11.83% | 3.24% |
| ROE | 8.31% | 21.04% |
| ROIC | 8.84% | 9.76% |
Dividends
| Metric | PFE | TGT |
|---|---|---|
| Dividend yield | 6.97% | 3.25% |
| Payout ratio | 126.47% | 55.88% |
Growth (annualized)
| Metric | PFE | TGT |
|---|---|---|
| Revenue CAGR (5Y) | 8.22% | -0.29% |
| EPS CAGR (5Y) | -3.78% | -1.34% |
| FCF CAGR (5Y) | -3.79% | -17.01% |
| Total return CAGR (5Y) | -5.21% | -8.75% |
Frequently asked
- Which has the lower trailing P/E, PFE or TGT?
- TGT has the lower trailing P/E: PFE trades at 18.83 and TGT at 18.54. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, PFE or TGT?
- Over the past five years, PFE grew revenue faster — PFE at a 8.22% CAGR versus TGT at -0.29%.
- Does PFE or TGT pay a bigger dividend?
- PFE yields 6.97% and TGT yields 3.25% based on trailing dividends and the latest price.
- Is PFE or TGT more profitable?
- PFE runs the higher net margin — PFE at 11.83% versus TGT at 3.24%.
- How have PFE and TGT total returns compared?
- Over the past 10 years, PFE delivered 1.55% and TGT delivered 9.69% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Pfizer P/E ratioTarget P/E ratioPfizer dividend yieldTarget dividend yieldPfizer ROETarget ROEPfizer operating marginTarget operating marginPfizer revenue growthTarget revenue growthPfizer free cash flowTarget free cash flow
Pfizer & Target appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.